Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05047224 · ClinicalTrials.gov registry record · NA
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool
A NA study of Autism Spectrum Disorder, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 720
- Enrollment target
- 1
- Study location
NCT05047224 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 720 participants, above the 132-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (445% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05047224, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 720 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to evaluate the use of a telemedicine tool, the TELE-ASD-PEDS (TAP), that is designed to assess for autism spectrum disorder (ASD) symptoms in toddlers. The TAP was developed at VUMC by a team of clinical psychologists with expertise in the early identification of ASD. The TAP has been studied in controlled laboratory settings, with high levels of family and clinician satisfaction, as well as excellent agreement with blinded comprehensive ASD evaluation. The TAP has also been used to complete direct-to-home telemedicine assessments during the COVID-19 pandemic. However, the investigators have not yet compared direct-to-home assessments using the TAP with gold standard, in-person ASD assessments. It has also not yet been studied in a diverse sample of families or with providers outside of VUMC. This study will allow the investigators to address those gaps.
Conditions Studied
Interventions
- BEHAVIORAL Tele-assessment + in-person assessment
- BEHAVIORAL Tele-assessment only
Study Locations (1)
California
- UC Davis MIND Institute - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2021-12-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05047224
The ClinicalTrials.gov registry entry for NCT05047224 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 132-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (445% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Tele-assessment + in-person assessment is the first listed.
NCT05047224 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05047224 about?
NCT05047224 is a clinical study titled "Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool". The investigators propose to evaluate the use of a telemedicine tool, the TELE-ASD-PEDS (TAP), that is designed to assess for autism spectrum disorder (ASD) symptoms in toddlers. The TAP was developed at VUMC by a team of clinical psychologists with expertise in the early identification of ASD. The ...
What is the current status of trial NCT05047224?
This trial is currently recruiting. It is a NA study. The enrollment target is 720 participants. The study started on 2021-12-03. Estimated completion is 2026-06-30.
What conditions does trial NCT05047224 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT05047224?
The interventions under investigation include: Tele-assessment + in-person assessment (BEHAVIORAL), Tele-assessment only (BEHAVIORAL).
Who is sponsoring clinical trial NCT05047224?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05047224 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.